Alterations in death receptor signaling can contribute to various diseases. In cancer, tumor cells often develop mechanisms to evade death receptor-mediated apoptosis, such as downregulating receptor expression or overexpressing c-FLIP, which inhibits caspase activation. In contrast, excessive death receptor activation can lead to tissue damage in autoimmune diseases, where healthy cells are mistakenly targeted.
